We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid test... read more Featured Products: More products

Download Mobile App





CerTest Showcases Latest Innovations in Diagnosis of Infectious Diseases

By LabMedica International staff writers
Posted on 12 Nov 2024

CerTest Biotec (Zaragoza, Spain) is ending the 2024 exhibition calendar with its participation in this year’s MEDICA. More...

With more than 5,300 exhibitors from almost 70 different countries, MEDICA is one of the largest medical B2B exhibitions in the world. CerTest is presenting again at MEDICA this year, highlighting the different medical diagnostic technologies it has developed to over 83,000 visitors expected at the event. At MEDICA 2024, Certest is showcasing the V-Flex system that is part of its VIASURE Complete Solution designed to achieve a better molecular diagnostic workflow. The VIASURE V-FLEX system is a new fully automated solution in molecular biology for nucleic acid extraction, purification, and PCR set-up from biological matrix and samples. The instrument has been designed with flexible configurations to meet different user needs.

Visitors to the Certest booth can also learn about the VIASURE DNA/RNA pathogen extraction kit designed to extract from various biological samples: swabs, saliva, sputum, bronchoalveolar lavages, fecal and urine samples. The kit is based on magnetic particles, which allows its automation for high throughput analysis, reducing hands-on time and improving reproducibility. The extraction kit is currently optimized for two types of magnetic separation methods: VIASURE V-Flex and KingFisher Flex. Certest is also demonstrating the VIASURE V-Smart software that allows the analysis and interpretation of the VIASURE Real-Time PCR assays. VIASURE V-Smart facilitates the conversion of the PCR raw data into test results with minimal manual intervention.

Related Links:
CerTest Biotec


Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hemodynamic System Monitor
OptoMonitor
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.